What the NHS can learn from global healthcare tech

Old-fashioned processes are inhibiting rapid innovation across the NHS. Here's how three other major healthcare systems around the world are approaching advances in technology

How teledermatology could help the NHS

For mild or moderate skin conditions, patients and doctors are increasingly turning to teledermatology

People with skin disease deserve better

From long waiting times to a lack of trained professionals, it is high time that policymakers stood up to do more to help patients with skin conditions

What is a dermatologist?

The alarmingly small number of qualified dermatologists in the UK must be addressed, along with a widespread misunderstanding of what they actually do

Diagnosis is just the beginning of the battle

The UK lags behind other countries in getting the right treatments to rare disease patients, but promising developments are underway in a bid to help improve access

How rare diseases can impact mental health

Mental health is fast becoming recognised as the missing piece of the puzzle in rare disease support

Why buyers’ clubs are the last option for desperate families

How an ongoing pricing battle between the NHS and an American biopharmaceutical giant led to a buyers’ club for cystic fibrosis drugs in the UK

Why are orphan drugs so expensive?

Current methods to determine the right value for orphan drugs remain controversial, yet the fast-tracking of new therapies marks a big step forward for the industry